Overview

Welcome to the ABSORICA LD C‑A‑R‑E Program Website. This is a resource for patients that provides important safety information about ABSORICA LD to be read fully before starting therapy.

About ABSORICA LD

The active ingredient in ABSORICA LD is called isotretinoin, which is related to vitamin A. It belongs to a class of drugs called retinoids.

Isotretinoin is a prescription medicine to treat severe forms of acne that cannot be cleared up by any standard acne treatments, including antibiotics.

Serious side effects are possible

Please be aware of significant warnings for people taking ABSORICA LD, such as the high potential of birth defects and other health problems. Read through all pages of this site, as well as the Patient Medication Information that comes with your prescription for ABSORICA LD, especially the important warnings for patients and important signs and symptoms that mean you must call your doctor.

Before starting ABSORICA LD, your doctor will talk to you about the possible benefits and side effects of ABSORICA LD and ask you to read and sign a document called an Informed Consent Form that shows that you understand the serious risks of ABSORICA LD.

For more information

For more information about side effects, please read the Patient Medication Information document given to you with your ABSORICA LD prescription or click here.

For more information on ABSORICA LD, click here for the ABSORICA LD Clinical Awareness Resource and Education C‑A‑R‑E Program: An Educational Guide for Patients.

Resources

Below are C‑A‑R‑E Program resources to help you learn more about ABSORICA LD, including how to take it, common side effects, risks, and important safety information. Be sure to talk to your doctor if you have any questions about ABSORICA LD.

ABSORICA LD Clinical Awareness Resource and Education C-A-R-E Program: An Educational Guide for Patients thumbnail

ABSORICA LD Clinical Awareness Resource and Education C‑A‑R‑E Program: An Educational Guide for Patients

A guide detailing important things you need to know before starting ABSORICA LD, including how to take it, common side effects, and important safety information.

Download
Patient Informed Consent Form thumbnail

Patient Informed Consent Form

You will need to review this form with your physician and sign it before you start treatment with ABSORICA LD. The form is designed to ensure that patients have been counselled about therapy with ABSORICA LD and understand the risks.

Download
ABSORICA LD Product Monograph thumbnail

ABSORICA LD Product Monograph

This document is intended to provide you with the necessary information on the conditions of use and important safety warnings and precautions when taking ABSORICA LD.

Download

Contact Us

For information about birth control or for confidential counselling:

Call: 1-833-388-0532

Email: Med.InfoCanada@sunpharma.com

Visit Website: www.AbsoricaLD.ca

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding a Sun Pharma product, please email Med.InfoCanada@sunpharma.com or call 1-833-388-0532. You can also report adverse events relating to any product to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.

Sun Pharma logo

Sun Pharma Canada Inc.

126 East Drive Brampton, ON

L6T 1C1, Canada

https://sunpharma.com/canada/

Phone: 1-844-924-0656

(PR)ABSORICA LD logo
PAAB logo